Seattle's Children Cancer Center
Seattle, Washington 98101
We've found
1 trials
at this facility
Ewing Sarcoma Clinical Trial
Updated: 12/31/1969
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
